Bragar Eagel & Squire, P.C. Is Investigating Verrica, Gap, and Corcept and Encourages Investors to Contact the Firm
03 juin 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, June 03, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Verrica Pharmaceuticals,...
Bragar Eagel & Squire, P.C. Is Investigating Medallion, Corcept, RBB, and Cassava and Encourages Investors to Contact the Firm
29 mai 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 29, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Medallion Financial Corp....
Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Corcept, and RBB and Encourages Investors to Contact the Firm
22 mai 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 22, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against CareDx, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Corcept, and RBB and Encourages Investors to Contact the Firm
16 mai 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 16, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against CareDx, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Corcept, and RBB and Encourages Investors to Contact the Firm
11 mai 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 11, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against CareDx, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating Corcept, RBB, and Verra and Encourages Investors to Contact the Firm
06 mai 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 06, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Corcept Therapeutics, Inc....
Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Cortexyme, and Corcept and Encourages Investors to Contact the Firm
01 mai 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 01, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against CareDx, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating Cortexyme, Corcept, RBB, and Verra and Encourages Investors to Contact the Firm
25 avr. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Cortexyme, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating Cortexyme, SelectQuote, Corcept, and Core Scientific and Encourages Investors to Contact the Firm
20 avr. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Cortexyme, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating Corcept, Core Scientific, Anavex, and Roblox and Encourages Investors to Contact the Firm
15 avr. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 15, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Corcept Therapeutics,...